Stock SPRY ARS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart ARS Pharmaceuticals, Inc.

Equities

SPRY

US82835W1080

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
8.96 USD +1.47% Intraday chart for ARS Pharmaceuticals, Inc. +0.90% +63.50%
May. 09 ARS Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 30 ARS Pharmaceuticals, Inc. Submits Response for Neffy (Epinephrine Nasal Spray) Marketing Authorization Application to EMA's Chmp CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ARS PHARMACEUTICALS, INC. Stock ARS Pharmaceuticals, Inc.
 865M - -
MODERNA, INC. Stock Moderna, Inc.
 62.59B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 41.18B
LONZA GROUP AG Stock Lonza Group AG
 40.29B
CELLTRION, INC. Stock Celltrion, Inc.
 27.9B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.21B
  1. Stock Market
  2. Equities
  3. SPRY Stock
  4. Charts ARS Pharmaceuticals, Inc.
  5. Sector Chart